In Vitro Diagnostics | Research, Development, Test, and Evaluation
Biological Threat Agents
MRIGlobal’s services span all stages of in vitro diagnostic product development process, beginning with research and development.
Our research, development, testing, and evaluation supporting biological threat agent disease diagnostics includes molecular and immunological assay method and platform development. Our work leads clients through clinical validation, including FDA 510(k), Pre-Market Notification (PMN), and CE Mark Submissions.
We develop assays and protocols related to biological threat disease diagnostics:
Molecular and immunological
Next Generation Sequencing
Prototype development of sample collection, testing, preservation, and transport solutions for austere, non-conventional, and traditional laboratories
Theresa Seitz prepares a sample for testing on a point-of-care diagnostic device.
MRIGlobal scientists conduct research, development, testing, and evaluation to support biological threat disease diagnostic technology innovation. The goal of this support is to ultimately result in an FDA-cleared product.
Work with Us
Learn more about how MRIGlobal can test and evaluate your chemical and biological approaches by contacting us or by using our Project Quote Tool.